Dolutegravir/lamivudine FDC recommended by NHS England

Simon Collins, HIV i-Base

On 12 March 2020 the specialised commissioning document for dolutegravir/lamivudine was published.

The was after what is alwasy a long protracted process, even with the best intentions for faster access.

Doctors should now be able to prescriber this single-pill formulation, in line with prescribing guidelines.


NHS England. Dolutegravir / lamivudine for the treatment of Human Immunodeficiency Virus (HIV-1) infected adults and adolescents over 12 years of age

Links to other websites are current at date of posting but not maintained.